A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1994
12/08/1994	CA2164003A1 Pharmaceutical thermal infusion process
12/08/1994	CA2163772A1 Intramuscular and subcutaneous injection solution for animals
12/08/1994	CA2163340A1 A drug delivery composition for alpha-adreno receptor blocking agents
12/08/1994	CA2163227A1 Vitamin b12 mediated oral delivery systems for gcsf and epo
12/08/1994	CA2163226A1 Amplification of the vitamin b12 uptake system using polymers
12/08/1994	CA2163225A1 Lhrh antagonists
12/08/1994	CA2163089A1 Nasal drug delivery composition containing nicotine
12/08/1994	CA2141028A1 Hepatotropic conjugates of antiviral drugs, carriers thereof and pharmaceutical compositions containing them
12/07/1994	EP0627632A1 Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
12/07/1994	EP0627446A1 Sulfonated derivatives of cyclomalto-oligosaccharides, process for their preparation and carrier for active substances which contains these derivatives
12/07/1994	EP0627222A1 Infusion and injection compositions containing dexamethasone-21-phosphate-disodium salt and polysorbate
12/07/1994	EP0626974A1 Mitogen-free substance, its preparation and its use.
12/07/1994	EP0626865A1 Use of the conjugate of a fgf and a saporin for treatment of ocular pathologies
12/07/1994	EP0626864A1 Topical composition containing hyaluronic acid and nsaids
12/07/1994	EP0626863A1 Formulations containing hyaluronic acid
12/07/1994	EP0626862A1 Drug system
12/07/1994	EP0626857A1 Improved peritoneal dialysis solutions with polypeptides
12/07/1994	EP0626855A1 Health and beauty aid compositions
12/07/1994	EP0626850A1 Dry compositions for preparing submicron emulsions
12/07/1994	CN1095953A Galenic matrices, preferably in the form of microspherules
12/07/1994	CN1095952A Method for production of medicated tea
12/07/1994	CN1095921A Ointments for burn and scald and making method thereof
12/07/1994	CN1026861C Pharmaceutical compositions having good stability
12/07/1994	CA2097892A1 Prevention and control of cancer
12/06/1994	US5371199 Substituted porphyrins, porphyrin-containing polymers, and synthetic methods therefor
12/06/1994	US5370901 Forming microballoons of contrast material grafted to silane coupler and bound to carrier; having adhesive affinity for gastrointestinal mucosa; NMRI and ultrasonic echography
12/06/1994	US5370880 Pharmaceutical formulations containing acrivastine
12/06/1994	US5370879 Formulations and their use in the treatment of neurological diseases
12/06/1994	US5370877 Method for improving delivery and reducing toxicity of biologically active substances using novel α-amino dicarboxylic acid derivatives
12/06/1994	US5370872 Coupling lipid a free polysaccharide to toxin A
12/06/1994	US5370869 Infusion into patient platelet concentrate that has been in contact with povidone-iodine or povidone-hydrogen peroxide or mixture to inactivate or destroy pathogenic microorganism
12/06/1994	US5370815 Peroxidase, peroxide, iodide compound, and surfactants and buffers; enzyme generated free iodide radical
12/06/1994	CA1333363C Angiogenesis inhibitor comprising fumagillin
12/06/1994	CA1333359C Dental therapy by vesicle delivery
12/01/1994	DE4418115A1 Pharmaceutical preparations contg macrolide antibiotics
11/1994
11/30/1994	EP0626450A2 Ubiquitin conjugating enzyme (E2) fusion proteins
11/30/1994	EP0626447A1 Monoclonal antibodies and Fv specific for cd2 antigen
11/30/1994	EP0626173A1 Aerosol composition containing fusafungine
11/30/1994	EP0626171A1 Oxytetracycline or doxycycline injectable solution containing PVP and N-methylpyrrolidone and/or 2-pyrrolidone
11/30/1994	EP0626170A2 Stabilisation of pharmacologically active compounds in sustained release compositions
11/30/1994	EP0625993A1 Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
11/30/1994	EP0625910A1 Dual carrier immunogenic construct
11/30/1994	EP0625900A1 Compositions and processes for the sustained release of drugs.
11/30/1994	CN1026787C Preparation of 1-(2-acetyl-4-butyamidepenoxy) -2,3-epoxypropane
11/29/1994	US5369095 Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers
11/29/1994	US5368868 Nonionic surfactants of ethylene propylene oxide copolymers
11/29/1994	US5368865 Suspendible composition and process for preparing the same
11/29/1994	US5368864 Formulation of oxypurinol and/or its alkali and alkaline earth salts
11/29/1994	US5368862 Controlled delivery of drugs
11/29/1994	US5368858 Methods and compositions for the treatment and repair of defects or lesions in cartilage
11/29/1994	US5368852 Prolonged-release liquid type of pharmaceutical preparation comprising drug-resin complex and benzoate preservative
11/29/1994	US5368848 Cosmetic gel stick compositions
11/29/1994	CA1333257C Use of zinc hydroxide or iron hydroxide as adjuvant in antigen solutions, and antigen solutions containing such adjuvants
11/29/1994	CA1333256C Hyposensitization agent
11/28/1994	EP0663013A4 Method for delivering nucleic acids into cells.
11/28/1994	CA2124277A1 Methods for administering biological agents and microparticle compositions useful in these and other methods
11/26/1994	CA2124179A1 New fusafungine-based medicinal spray formulation, a process for its production and pharmaceuticals containing same
11/24/1994	WO1994026921A1 Production of toxin binding biopolymers, use thereof
11/24/1994	WO1994026915A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994	WO1994026910A1 Immunotoxins comprising gelonin and an antibody
11/24/1994	WO1994026778A1 Conjugation-stabilized polypeptide compositions
11/24/1994	WO1994026728A1 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use
11/24/1994	WO1994026311A1 Anthracycline conjugates, their preparation and their use as antitumor agents
11/24/1994	WO1994026310A1 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
11/24/1994	WO1994026309A1 Solubilizing agent and external preparation containing the same
11/24/1994	WO1994026302A1 Stable liquid compositions of gamma interferon
11/24/1994	WO1994026297A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
11/24/1994	WO1994026291A1 Therapeutic inhibitor of vascular smooth muscle cells
11/24/1994	WO1994026267A1 Compositions in the form of solid solutions
11/24/1994	WO1994026266A1 High dose formulations
11/24/1994	WO1994026257A1 Transdermal therapeutic system containing estradiol
11/24/1994	WO1994026255A1 Solid fat nanoemulsions as vaccine delivery vehicles
11/24/1994	WO1994026254A1 Incorporation of taxol into liposomes and gels
11/24/1994	WO1994026252A1 Solid fat nanoemulsions as drug delivery vehicles
11/24/1994	WO1994026250A1 Method for treating neurological disorders
11/24/1994	WO1994026130A1 Cholesterol lowering drink mix compositions
11/24/1994	WO1994026110A1 Stable quinolone and naphthyridine premix formulations
11/24/1994	WO1994020512A3 Analogs for specific oligosaccharide-protein interactions and uses therefor
11/24/1994	CA2163255A1 Compositions in the form of solid solutions
11/24/1994	CA2162602A1 Gene transfer into pancreatic and biliary epithelial cells
11/23/1994	EP0625355A1 Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient
11/23/1994	EP0625311A1 Sugar-free, hard-coating-process and so obtained products
11/23/1994	EP0625207A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr)
11/23/1994	EP0625203A1 Synthetic haemophilus influenzae conjugate vaccine
11/23/1994	EP0625068A1 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them
11/23/1994	EP0625055A1 Use of fullerenes in diagnostic and/or therapeutic agents
11/23/1994	EP0625044A1 Compositions for nasal administration containing polar metabolites of opioid analgesics
11/23/1994	EP0625034A1 Skin adhesive hydrogel, its preparation and uses
11/23/1994	CN1095267A Tablets with improved bioavailability of the active material clodronic acid
11/23/1994	CN1095266A 可注射组合物 Injectable compositions
11/23/1994	CN1095265A Stabilized medicinal aerosol solution formulations
11/22/1994	US5367080 Pyridine derivatives
11/22/1994	US5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/22/1994	US5366958 Localized delivery using fibronectin conjugates
11/22/1994	US5366737 Drug delivery, DNA transfection
11/22/1994	US5366730 Stabilized compositions having human tissue type plasminogen activator enzymatic activity
11/22/1994	CA1333153C Aqueous emulsion for pharmaceutical dosage form
11/17/1994	EP0624599A2 Derivatives of mono (6-amino-desoxy)cyclodextrin substituted in position 6 with an alpha aminoacid group, process of their preparation and applications
11/17/1994	EP0624377A2 Lysosomal enzyme-cleavable antitumor drug conjugates
11/17/1994	EP0624375A2 Pharmaceutical compositions containing hirudin

1 ... 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 ... 1712